AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) announced it has received a Health Canada Class 3 Device License approval for its comprehensive genotyping assay, xTAG® CYP2D6 Kit v3. Identification of patient CYP2D6 genotypes can help clinicians individualize drug treatment by selecting appropriate therapies. The xTAG(R) CYP2D6 Kit v3 is a qualitative genotyping assay which can […]
SANTA CLARA, Calif. -– Agilent Technologies Inc. (NYSE: A) today announced that the China Food and Drug Administration has approved the company’s SureScan Dx microarray scanner as a medical device for in vitro diagnostic use. “Bringing microarray scanning technology to clinical-quality standards is an important milestone in moving the advancement of genome-wide chromosome analysis to […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) announced today the issuance of 14 new patents covering a wide range of the core technologies of BioTime and its subsidiaries Asterias Biotherapeutics, Inc. (NYSE MKT: AST), OrthoCyte Corporation, ES Cell International Pte Ltd, OncoCyte Corporation, and ReCyte Therapeutics, Inc. The new patents issued over Q3 and […]
MOUNTAIN VIEW, CA -– Appistry, Inc., a leading provider of tools, software, and services that enable healthcare institutions to practice genomically enhanced medicine, today launched a cloud-based system for conducting patient-centered translational research. Appistry CloudDx? Translational meets a critical need in clinical research centers: centralizing and coordinating data, processes, and communication in order to leverage […]
BOSTON and SAN FRANCISCO — Cartagenia, the leader in providing genetic labs and clinicians with software-based workflow support for variant assessment, lab reporting, and access of relevant knowledge bases, today announced a partnership with MedGenome Inc, the developer of the OncoMD Cancer knowledge base. OncoMD is an industry-leading cancer analytics platform that includes a curated, […]
WALTHAM, Mass. (USA) and Suzhou (CHINA) — PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the opening of Suzhou PerkinElmer Medical Laboratory Co., Ltd. in China. More than 130 local government officials, key opinion leaders, medical research professionals and academics recently attended a ceremony […]
LONDON & ALBUQUERQUE, N.M. — DNA Electronics Ltd (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for blood infections, has on 15 January 2015 completed the acquisition of the entire issued share capital of nanoMR Inc. (‘nanoMR’), an Albuquerque based developer of a novel system for rapid […]
PROVIDENCE, R.I. and PARIS — Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in oncology, and Ariana Pharmaceuticals SA, a developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, today announced a collaboration that aims to identify sets of DNA structural variants linked to prostate and […]
PARIS — DIAXONHIT (Alternext : ALEHT, FR0004054427), a French leader in specialty in-vitro diagnostics for transplantation, infectious diseases and cancer, announces today that the CE marking of its BJI InoPlex® diagnostic test, the first blood test to aid in the diagnosis of prosthetic bone and joint infections, was completed late 2014 as scheduled. This regulatory […]
Danvers, Mass. -– Beckman Coulter Genomics, a leading provider of DNA Sequencing Services announces today accreditation from the College of American Pathologists (CAP). Furthering a long-standing commitment to delivering state-of-the-art sequencing services and high levels of customer satisfaction, the facility in Danvers completed a comprehensive on-site inspection as part of the CAP’s Accreditation Programs. The […]
Pay Invoice
Latest Blogs
-
Syncell: Advancing Spatial Proteomics
June 30, 2025 3:41 pm
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
